Memorial Sloan Kettering hematologic oncologist Urvi Shah

Urvi A. Shah, MD

Hematologic Oncologist

Clinical Expertise

Multiple Myeloma; Smoldering Myeloma; Monoclonal Gammopathy of Undetermined Significance (MGUS); Related Plasma Cell Disorders

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Shah accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me

Education

MD, Grant Medical College

Residencies

Internal Medicine - Tufts Medical Center

Fellowships

Adult Cancer Immunotherapy - Memorial Sloan Kettering Cancer Center; Hematology and Medical Oncology - Montefiore Medical Center & Albert Einstein College of Medicine

Board Certifications

Internal Medicine; Medical Oncology

I am a board-certified hematologic oncologist with expertise in diagnosing and treating plasma cell disorders. These include multiple myeloma, smoldering myeloma, and monoclonal gammopathy of undetermined significance, among others. I work as part of a multidisciplinary team caring for people with these cancers.

During my oncology fellowship training, I needed chemotherapy for Hodgkin’s lymphoma. My firsthand experience on the other side of the doctor-patient relationship has helped me relate to patients in a more compassionate and empathic way. I find that clear, effective communication with patients, family members, and doctors can be crucial to prevent unnecessary stress and help in recovery.

I conduct clinical and translational research into plasma cell disorders. My research focuses on developing and testing new treatments for these disorders. I am particularly interested in the role of nutrition, the microbiome, epigenetics, and the immune system in the development of these diseases. Thus, identifying methods to prevent its progression or relapse.

I am currently involved in a number of clinical trials that are looking at novel immune therapies, including chimeric antigen receptor T cells. At MSK, our patients have access to the latest therapies, including immune-based therapies for plasma cell disorders. Sometimes this is through a clinical trial but it can also be part of our standard care. I value patients’ goals for their care and treatment very strongly. I work closely with them to come up with a care plan that suits their needs and also allows the best possible treatment strategy.

In my free time, I enjoy painting with mixed media, staying active, and being outdoors, especially hiking trails around New York City.

I find that clear, effective communication with patients, family members, and doctors can be crucial to prevent unnecessary stress and help in recovery.

Dr. Shah

Awards and Honors

  • Henry L. Moses Prize for Best Clinical Paper, Montefiore Medical Center (2019)
  • ASCO/AACR Methods in Clinical Cancer Research Workshop (2018)
  • Second Place, Outstanding Fellow Research Award, Albert Einstein College of Medicine and Montefiore Medical Center Research Symposium (2018)
  • American Society of Hematology Abstract Achievement Award (2017)
  • ECOG-ACRIN Young Investigator Symposium Distinction Award for Translational Research (2017)
  • Chief Fellow, Hematology Rotation, Montefiore Medical Center (2017)
  • Outstanding Emergency Department Resident Award, Tufts Medical Center (2015)

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Shah UA, Chung E, Giricz O, Pradhan K, Kataoka K, Gordon-Mitchell S, Bhagat T, Mai Y, Wei Y, Ishida E, Choudhary G, Joseph A, Rice R, Gitego N, Bartenstein M, Goel S, Mantzaris I, Shastri A, Parrish C, Derman O, Binder A, Gritsman K, Kornblum N, Braunschweig I, Bhagat C, Hall J, Graber A, Ratner L, Wang Y, Ogawa S, Verma V, Ye BH, Janakiram M. North American ATLL has a Distinct Mutational and Transcriptional Profile and responds to epigenetic therapies. Blood 2018 Aug 13, PMID: 30104217.

Publications on PubMed

Visit PubMed for a full listing of Dr. Shah’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.